In this study, we investigated the effects of BMPR2 mutations on lung development by generating airway and alveolar organoids derived from induced pluripotent stem cells (iPSCs) obtained from patients with BMPR2-related pulmonary arterial hypertension, as well as gene-corrected control iPSCs. Here, BMPR2 is linked to pulmonary arterial hypertension.